STAT+: Trump’s health care affordability czar takes aim at hospitals 
STAT News
Plus a buried alcohol study gets published, and a Biosecure update.
Showing all stories.
STAT+: The shortage of many medicines in the U.S. remains a ‘systemic’ problem, a new analysis finds
The number of prescription drug shortages in the U.S. fell by 23% last year, but a new analysis found other troubling signs about medicines in short supply.
Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cuts STAT News
The condemnations keep coming after five diabetes experts were escorted out of an ADA meeting for handing out copies of an editorial criticizing federal research cuts.
FDA OKs first new sunscreen ingredient in more than 25 years STAT News
Federal health regulators on Tuesday signed off on the first new sunscreen ingredient for the U.S. market in more than 25 years.
Trump administration warns more than 500 hospitals to provide more price information or face fines STAT News
The Trump administration has warned more than 500 hospitals that they are failing to provide the public with basic pricing information.
Gilead and Merck’s latest trial success and flop STAT News
AstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition, and more biotech news from The Readout
STAT+: NIAID appoints new acting director after weekslong questions over leadership STAT News
The NIH has appointed researcher John Powers III to lead its infectious disease institute on an acting basis, after weeks of being in leadership limbo.
STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more STAT News
GSK agreed to buy Nuvalent, a cancer drug developer, in a deal worth $10.6 billion, as the company continues its expansion in oncology
Dexcom RCT suggests CGM benefits for broad diabetes population STAT News
In this edition of STAT Health Tech: Dexcom's CGM trial, udpates from Apple's annual developers' conference, and wearables.
STAT+: NIH staffers published a letter of dissent a year ago. They feel it’s been ignored STAT News
In a report published on the first anniversary of the Bethesda Declaration, 71 staffers write that they feel NIH leadership “largely ignored" their concerns.
STAT+: What’s changed since the last major Ebola outbreak STAT News
A suppressed federal alcohol report, an "inevitable development" for wearables data, and more health news from Morning Rounds
Opinion: Why STAT is sticking with ‘health care’ as two words STAT News
Is it “health care” or “healthcare”? STAT readers had strong feelings.
STAT+: Wearables, and the flood of data they generate, inch closer to entering the clinic STAT News
Wearables generate a lot of health data, but it exists outside the clinic for the most part. New moves from Oura and Whoop may change that.
Opinion: Ending animal testing could set back xenotransplantation just as the field is poised for a breakthrough STAT News
“Innovations like xenotransplantation would never have reached clinical trials without animal experimentation,” writes transplant surgeon Joshua Mezrich.
A leader of the 2014 U.S. Ebola response compares then to now STAT News
As the world deals with an outbreak of Ebola that has no known cure, Susan Reichle, who last year co-founded Aid Transition Alliance to support former USAID professionals, discusses the…
STAT+: Trump’s health care affordability czar touts Medicaid cuts to hospital leaders STAT News
Hospital execs say they're working to mitigate the impacts of the looming cuts.
STAT+: GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B STAT News
GSK is buying Nuvalent, the maker of targeted cancer drugs, for $10.6 billion, a sizable addition to the latest run of biopharma acquisitions.
Alcohol study discarded by Trump officials is published in scientific journal STAT News
A government-commissioned study had been meant to inform new dietary guidelines, and found risks associated with even light drinking.
As Screwworm Cases Mount, U.S. Officials Ramp Up Response 
NYT Health
The parasitic, flesh-eating fly has now been confirmed in cows, goats and dogs.
Scientists found a new Alzheimer’s trigger and a drug that stops it 
ScienceDaily Health
Researchers have identified a new Alzheimer’s target and created an experimental compound that blocks a damaging process inside brain cells. In mice, the treatment slowed nerve cell loss, reduced Alzheimer’s-related changes, and even appeared to promote healthier aging.
Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or rest STAT News
Health workers at the epicenter of Congo's Ebola outbreak are laboring with little pay or rest.
STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials STAT News
AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.
STAT+: UnitedHealthcare’s lactation billing feud, and fake strokes STAT News
The biggest U.S. health insurer is changing how it pays for lactation counseling, and it could cut payment for many providers.
STAT+: Novo underwhelmed by drug it once fought Pfizer for STAT News
Revolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech news
STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more STAT News
Lilly disclosed new data that provide more details on the safety and tolerability of its next-generation obesity drug retatrutide
STAT+: J&J spends $1 billion to enter KRAS race for cancer treatments STAT News
Johnson & Johnson said it will purchase the startup Firefly Bio for $1 billion in an effort to expand its work in the suddenly buzzy field of KRAS inhibitors.
Major readouts from the annual diabetes conference STAT News
Why "Schedule F" matters, the Ebola outbreak response, and more health news from Morning Rounds
STAT+: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate STAT News
A combination of pancreatic cancer drugs from Tango Therapeutics and Revolution Medicines led to a strong response rate in an early-stage trial.
When it’s time to save a limb, novel clinic meets unhoused people where they are STAT News
Unmet vascular needs can lead to limb loss among unhoused patients. An unusual Massachusetts General Hospital program meets patients where they are.
Opinion: $2 million gene therapy cures require a financing model STAT News
“We do not lack cures. We lack the infrastructure to pay for and deliver them,” writes William Padula.
Opinion: American horses are obese, too STAT News
“American horses are getting sick in ways that look remarkably familiar,” writes Joshua Moen.
Dementia risk linked to nitrate in drinking water, study finds ScienceDaily Health
A major long-term study of more than 54,000 adults found that where nitrate comes from may matter far more than how much you consume. People who got more nitrate from vegetables—roughly the amount in a cup of baby spinach a day—had a lower risk of developing dementia, while higher nitrate and nitrite intake from red meat, processed meat, and even drinking water was linked to a greater risk.
Doctors thought this kidney drug helped some patients. It may help millions more. ScienceDaily Health
A trio of major studies found that finerenone may protect the kidneys and heart in far more people than previously thought. The drug significantly slowed kidney disease progression and reduced the risks of kidney failure, heart failure, cardiovascular death, and overall mortality. Researchers saw benefits not only in patients with diabetes but also in those with non-diabetic kidney disease, a group with limited treatment options.
STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADA STAT News
You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference.
STAT+: New data may cast doubt on competitiveness of Boehringer’s obesity drug STAT News
Boehringer Ingelheim’s obesity drug showed promise in cutting liver fat, but it was less impressive at overall weight loss, new data shows.
Ancient Chinese medicine could transform hair loss treatment ScienceDaily Health
A traditional Chinese medicinal root used for over a thousand years is attracting new scientific attention for its potential to combat hair loss. Studies suggest Polygonum multiflorum can block harmful hormones, activate hair-growth signals, protect follicles, and boost blood flow to the scalp. Researchers say the herb’s effects align remarkably well with both ancient descriptions and modern hair biology.
STAT+: Triple hormone receptors, a monthly obesity drug, and a bittersweet ending STAT News
You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference in New Orleans.
STAT+: Lilly shares safety, tolerability data on its next-gen obesity drug STAT News
Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association on Saturday.
STAT+: Detailed data show Pfizer’s monthly obesity drug continues to show potential STAT News
Detailed data from a midstage study offered further evidence that the obesity drug Pfizer acquired from the biotech Metsera could be dosed monthly.
Scientists sound the alarm as dangerous amoebas spread globally ScienceDaily Health
Scientists warn that free-living amoebae may be an underappreciated public health threat, capable of causing deadly infections and shielding other dangerous microbes from water treatment. Climate change and aging infrastructure could help these resilient organisms spread more widely in the years ahead.
No matching stories
Try another keyword or clear the search box.
